Seeking Alpha

Illumina (ILMN), which makes equipment to analyze DNA, is -14% early on after lowering its Q2...

Illumina (ILMN), which makes equipment to analyze DNA, is -14% early on after lowering its Q2 and full-year revenue outlook to $161M from a previous $168-173M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs